Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
Genevaz
D
D
INSERM U430, Hôpital Broussais, Paris, France.
Latremouille
C
C
Goussev
N
N
Carpentier
A
A
Glotz
D
D
D000818:Animals; D003165:Complement System Proteins / Q000032:analysis; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000276:immunology*; D007141:Immunoglobulin Fc Fragments / Q000276:immunology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D051381:Rats; D012709:Serum Albumin; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D007140:Immunoglobulin Fab Fragments; D007141:Immunoglobulin Fc Fragments; D016756:Immunoglobulins, Intravenous; D012709:Serum Albumin; D003165:Complement System Proteins